To view or add a comment, sign in Roches Enicepatide (CT-388) is emerging as a serious contender in obesity care
When a person uses semaglutide, their body responds by feeling less hungry and feeling full sooner after eating
This anabolic signaling is a key driver behind the strength and size gains attributed to IGF-1 LR3
Individuals currently taking medications, managing existing health conditions, or considering changes to their health regimen should consult a physician before starting any new prescription treatment
If youre interested in exploring semaglutide as a weight loss option, visit Lasting Impressions Medical Spa for a consultation
This includes consuming regular, balanced meals and snacks that incorporate a mix of carbohydrates, proteins, and fats, and advising against long periods without food